1. What are the current Minnesota regulations regarding opioid prescriptions?
In Minnesota, there are strict regulations in place governing the prescription and dispensing of opioids to help combat the opioid epidemic. Some of the key regulations include:
1. Prescription Monitoring Program (PMP): Minnesota requires healthcare providers to consult the state’s PMP database before prescribing opioids to ensure patients are not obtaining excessive amounts of opioids from multiple sources.
2. Opioid Prescribing Guidelines: The Minnesota Board of Pharmacy has established guidelines for healthcare providers to follow when prescribing opioids. These guidelines emphasize the importance of risk assessments, informed consent, and periodic monitoring of patients receiving opioids.
3. Pain Clinic Certification: Pain management clinics in Minnesota must be certified by the state and adhere to certain standards to ensure the safe and appropriate prescribing of opioids.
4. Mandatory Education: Healthcare providers in Minnesota are required to complete continuing education on opioid prescribing practices to stay informed of the latest guidelines and best practices.
5. Prescription Limitations: There are restrictions on the quantity and duration of opioid prescriptions in Minnesota to reduce the risk of misuse and diversion.
Overall, these regulations aim to promote safe prescribing practices, prevent opioid misuse, and protect public health in Minnesota. It is important for healthcare providers to stay updated on these regulations to ensure compliance and contribute to the efforts to address the opioid crisis.
2. How does Minnesota define and regulate the use of painkillers?
In the state of Minnesota, the regulation of painkillers, including opioids, is primarily governed by both state and federal laws and regulations. Here is how Minnesota defines and regulates the use of painkillers:
1. Prescription Drug Monitoring Program (PDMP): Minnesota has a Prescription Monitoring Program that tracks the prescribing and dispensing of controlled substances, including painkillers. Healthcare providers are required to check the PDMP before prescribing opioids to patients to prevent overprescribing and identify potential cases of diversion or misuse.
2. Opioid Prescribing Guidelines: The state has established guidelines for healthcare providers on the safe and appropriate prescribing of opioids for pain management. These guidelines aim to reduce the risk of opioid misuse, addiction, and overdose by promoting responsible prescribing practices.
3. Pain Clinic Regulations: Minnesota has specific regulations governing pain management clinics to ensure they operate in compliance with state laws and provide safe and effective care to patients seeking treatment for chronic pain. These regulations include licensing requirements and quality standards for pain clinics.
Overall, Minnesota defines and regulates the use of painkillers through a combination of laws, programs, and guidelines designed to promote safe prescribing practices, prevent opioid misuse, and protect public health and safety.
3. Are there any specific laws in Minnesota related to opioid addiction treatment?
Yes, in Minnesota, there are specific laws related to opioid addiction treatment aimed at addressing the opioid crisis and supporting individuals struggling with addiction. Here are some key laws and regulations in Minnesota related to opioid addiction treatment:
1. The state has established the Prescription Monitoring Program (PMP) which requires healthcare providers to review a patient’s prescription history before prescribing opioids to prevent doctor shopping and identify potential cases of misuse or addiction.
2. Minnesota has also enacted the Opiate Product Registration law, which requires manufacturers of prescription opioid drugs to register with the state and pay a fee based on the quantity of opioids distributed in Minnesota. The funds collected are used to support prevention and treatment programs for opioid addiction.
3. Additionally, healthcare providers in Minnesota are required to follow specific prescribing guidelines when it comes to opioids, including conducting thorough patient assessments, providing education on risks and benefits, and considering alternative non-opioid treatments before initiating opioid therapy.
These laws and regulations in Minnesota demonstrate a comprehensive approach to addressing opioid addiction by focusing on prevention, monitoring, and treatment strategies.
4. What are the consequences of violating opioid prescribing laws in Minnesota?
In Minnesota, violating opioid prescribing laws can have severe consequences for healthcare providers. Some of the potential repercussions include:
1. Administrative Actions: The Minnesota Board of Medical Practice may take disciplinary actions against healthcare providers who violate opioid prescribing laws. This could include suspension or revocation of medical licenses, fines, or mandated continuing education.
2. Criminal Charges: Violating opioid prescribing laws in Minnesota may result in criminal charges, especially if the violation involves activities such as illegal distribution, prescription fraud, or drug diversion. Healthcare providers could face criminal prosecution, fines, and even imprisonment.
3. Civil Penalties: Violating opioid prescribing laws may also result in civil penalties, such as lawsuits from patients, government entities, or insurance companies. Providers may be held financially liable for damages resulting from improper opioid prescribing practices.
4. Loss of Reputation: Healthcare providers who violate opioid prescribing laws may suffer significant damage to their professional reputation. This could impact their ability to practice medicine, obtain malpractice insurance, or maintain relationships with patients and colleagues.
Overall, the consequences of violating opioid prescribing laws in Minnesota can be far-reaching and have long-lasting effects on healthcare providers both personally and professionally. It is crucial for providers to stay informed about and compliant with state regulations to avoid these severe outcomes.
5. How does Minnesota monitor the sale and distribution of painkillers?
Minnesota monitors the sale and distribution of painkillers through several regulations and systems in place:
1. Prescription Monitoring Program (PMP): Minnesota has a statewide Prescription Monitoring Program that tracks the prescribing and dispensing of controlled substances, including painkillers. Healthcare providers are required to report controlled substance prescriptions to the PMP database, allowing for monitoring of prescribing patterns and potential misuse.
2. Prescription Drug Monitoring: Pharmacists play a critical role in monitoring the sale of painkillers by checking the PMP database before dispensing controlled substances to ensure that patients are not obtaining multiple prescriptions from different providers, known as “doctor shopping.
3. Provider Education and Guidelines: Minnesota has implemented guidelines and educational programs for healthcare providers on responsible opioid prescribing practices. These guidelines aim to reduce the overprescribing of painkillers and promote safer opioid use for pain management.
4. Regulation and Enforcement: The state also enforces regulations on pain clinics, pharmacies, and healthcare providers to prevent diversion and abuse of painkillers. By closely monitoring these entities, Minnesota aims to limit the illicit distribution of opioids.
5. Collaboration with Law Enforcement: Minnesota works closely with law enforcement agencies to address illegal sales and distribution of painkillers. This collaboration helps identify and prosecute individuals and organizations involved in the illicit opioid trade, contributing to the overall efforts to monitor and control the distribution of painkillers in the state.
6. Are there any mandatory training requirements for opioid prescribing in Minnesota?
Yes, there are mandatory training requirements for opioid prescribing in Minnesota. Healthcare providers who have a DEA registration number and are authorized to prescribe controlled substances, including opioids, are required to complete at least two hours of continuing education on best practices in prescribing opioids and controlled substances every two years as part of their license renewal process. This training must include topics such as safe opioid prescribing practices, recognition of signs of opioid use disorder, and the use of the Prescription Monitoring Program (PMP) to prevent opioid misuse and diversion. Additionally, healthcare providers are encouraged to complete additional training on pain management and addiction to ensure safe and effective opioid prescribing practices.
1. The mandatory training requirements for opioid prescribing help ensure that healthcare providers are equipped with the knowledge and skills needed to safely and responsibly prescribe opioids to patients.
2. By staying up to date on best practices in opioid prescribing, healthcare providers can help mitigate the risks of opioid misuse, addiction, and overdose in their communities.
3. Compliance with these training requirements is essential for healthcare providers to maintain their licenses and uphold the standards of care in opioid prescribing set forth by the state of Minnesota.
7. What role do pharmacies play in implementing opioid regulations in Minnesota?
In Minnesota, pharmacies play a crucial role in implementing opioid regulations to help combat the opioid crisis.
1. Dispensing: Pharmacies are responsible for dispensing opioid medications to patients in accordance with state laws and regulations. They must ensure that prescriptions are legitimate and comply with dosage limits and refill restrictions set forth by the Minnesota Board of Pharmacy.
2. Monitoring: Pharmacies are required to participate in the state’s Prescription Monitoring Program (PMP), which tracks the prescribing and dispensing of controlled substances, including opioids. Pharmacists are expected to review patient history in the PMP database to prevent overprescribing, doctor shopping, and potential misuse of opioids.
3. Patient Education: Pharmacists have a duty to educate patients on the safe use, storage, and disposal of opioid medications. They may provide counseling on potential side effects, interactions with other medications, and the risk of opioid dependence and addiction.
4. Reporting: Pharmacies are mandated to report any suspicious or fraudulent opioid prescriptions to the appropriate authorities, such as the Drug Enforcement Administration (DEA) or Minnesota Board of Pharmacy. This helps prevent diversion and misuse of opioids within the community.
Overall, pharmacies play a vital role in implementing opioid regulations in Minnesota by ensuring the safe and appropriate use of these powerful medications while also actively participating in efforts to combat the opioid epidemic.
8. How are patients educated about the risks of opioid use in Minnesota?
In Minnesota, patients are educated about the risks of opioid use through various measures aimed at promoting safe and responsible consumption of these medications. Some key ways in which patients are educated about opioid risks in Minnesota include:
1. Healthcare provider-patient discussions: Healthcare providers in Minnesota are encouraged to have thorough discussions with patients about the potential risks and benefits of opioid therapy before prescribing these medications. This includes informing patients about the addictive nature of opioids, potential side effects, and alternatives to pain management.
2. Prescription drug monitoring programs: Minnesota has a Prescription Monitoring Program (PMP) in place, which allows healthcare providers to track patients’ controlled substance prescriptions. This helps in preventing overprescribing of opioids and promotes safe usage practices among patients.
3. Patient information leaflets: Pharmacies in Minnesota often provide patients with information leaflets or handouts that outline the risks associated with opioid use, proper dosage instructions, and ways to safely store and dispose of these medications.
4. Public awareness campaigns: State authorities and healthcare organizations in Minnesota frequently conduct public awareness campaigns to educate the general population about the risks of opioid misuse and ways to prevent addiction.
5. Mandatory continuing education: Healthcare professionals in Minnesota, including prescribers and pharmacists, are required to undergo continuing education on opioid prescribing guidelines and best practices. This helps in ensuring that healthcare providers are well-informed about the risks associated with opioids and can effectively communicate this information to patients.
9. What guidelines exist in Minnesota for prescribing painkillers to minors?
In Minnesota, there are specific guidelines and regulations in place for prescribing painkillers to minors to ensure their safety and prevent misuse or abuse. These guidelines typically include:
1. Obtaining informed consent from a parent or legal guardian before prescribing opioid painkillers to a minor.
2. Conducting a thorough assessment of the minor’s medical history, pain levels, and risk factors for opioid misuse before prescribing any painkillers.
3. Prescribing the lowest effective dose for the shortest duration possible to minimize the risk of addiction or overdose.
4. Monitoring the minor closely during treatment with painkillers and regularly reassessing the need for continued opioid therapy.
5. Providing education to both the minor and their parent or guardian on the risks and potential side effects of opioid painkillers, as well as safe storage and disposal practices.
These guidelines aim to balance the need for effective pain management in minors with the potential risks associated with opioid medications, highlighting the importance of careful prescribing practices and ongoing monitoring to promote safe and appropriate use of painkillers in this vulnerable population.
10. Are there any restrictions on the quantity of opioids that can be prescribed in Minnesota?
Yes, there are restrictions on the quantity of opioids that can be prescribed in Minnesota. The state has enacted legislation and regulations to address the opioid crisis and promote safe prescribing practices. Some key points regarding restrictions on opioid quantities in Minnesota include:
1. Limits on Initial Prescriptions: Minnesota law limits the quantity of opioids that can be prescribed for acute pain to a seven-day supply for adults who are not currently receiving opioid pain relief therapy.
2. Exceptions and Requirements: There are exceptions to this seven-day limit for certain circumstances, such as when a healthcare provider determines that a longer duration is necessary. In such cases, documentation and justification for the extended prescription are required.
3. Continuing Education: Healthcare providers in Minnesota are required to complete continuing education on best practices for prescribing opioids and managing pain. This education includes information on appropriate dosing, duration, and potential risks associated with opioid use.
4. Prescription Monitoring Program: Minnesota also has a Prescription Monitoring Program (PMP) in place, which requires healthcare providers to check a patient’s prescription history before prescribing opioids. This helps prevent overprescribing and identify patients who may be at risk for misuse or dependence.
Overall, Minnesota has implemented various restrictions and safeguards to promote safe opioid prescribing practices and mitigate the risks associated with opioid use and abuse. These measures aim to strike a balance between providing necessary pain relief for patients while preventing the misuse and diversion of opioids in the state.
11. How does Minnesota address opioid diversion and illegal distribution?
Minnesota addresses opioid diversion and illegal distribution through a combination of laws and regulations aimed at preventing the misuse of prescription painkillers.
1. Prescription Monitoring Program (PMP): Minnesota has a robust Prescription Monitoring Program that allows healthcare providers to track patients’ prescription history for controlled substances, including opioids. This helps identify potential cases of diversion or illegal distribution.
2. Drug Disposal Programs: The state has implemented various drug disposal programs to ensure safe and proper disposal of unused or expired medications, including opioids. This helps prevent these drugs from falling into the wrong hands.
3. Law Enforcement Efforts: Minnesota law enforcement agencies actively work to identify and prosecute individuals involved in the diversion and illegal distribution of opioids. This includes investigating instances of prescription fraud, doctor shopping, and illicit drug trafficking.
4. Enhanced Penalties: The state has implemented enhanced penalties for individuals convicted of opioid diversion and illegal distribution. These penalties serve as a deterrent and highlight the seriousness of these offenses.
5. Education and Awareness: Minnesota also focuses on educating healthcare providers, pharmacists, and the public about the risks of opioid diversion and misuse. By increasing awareness, the state aims to prevent these practices from occurring in the first place.
Overall, Minnesota’s efforts to address opioid diversion and illegal distribution involve a comprehensive approach that combines monitoring, enforcement, prevention, and education strategies.
12. Are there any special considerations for elderly patients receiving painkillers in Minnesota?
1. Elderly patients in Minnesota who are receiving painkillers need to be closely monitored due to their increased sensitivity to these medications. The aging process can affect how the body metabolizes drugs, making elderly individuals more susceptible to the side effects and potential risks associated with painkillers.
2. Minnesota has specific guidelines and regulations in place to ensure the safe prescribing and dispensing of painkillers to elderly patients. Healthcare providers are encouraged to conduct thorough assessments of elderly patients before prescribing painkillers, taking into consideration factors such as existing medical conditions, potential drug interactions, and the risk of addiction or misuse.
3. Additionally, healthcare providers in Minnesota are required to adhere to the state’s Prescription Monitoring Program (PMP) when prescribing painkillers to elderly patients. This program helps track and monitor patients who are receiving controlled substances, which can help prevent overprescribing and identify potential signs of abuse or diversion.
4. It is also important for healthcare providers to engage in open communication with elderly patients and their caregivers regarding the risks and benefits of painkiller use. Patient education and monitoring for side effects and signs of opioid misuse are crucial in ensuring the safe and effective use of painkillers in this vulnerable population.
5. Overall, special considerations for elderly patients receiving painkillers in Minnesota include close monitoring, individualized treatment plans, adherence to state regulations, and proactive communication between healthcare providers, patients, and caregivers. By taking these considerations into account, healthcare providers can help ensure the safe and appropriate use of painkillers in elderly patients while minimizing the risk of adverse events.
13. What steps has Minnesota taken to combat the opioid crisis?
Minnesota has implemented several initiatives to combat the opioid crisis within the state:
1. Prescription Monitoring Program (PMP): Minnesota has a robust PMP in place to track the prescribing and dispensing of controlled substances, including opioids. This helps healthcare providers identify potential cases of prescription drug diversion or over-prescribing.
2. Opioid Prescribing Guidelines: The state has developed and disseminated guidelines for healthcare providers to follow when prescribing opioids, with an emphasis on safe prescribing practices and the judicious use of these medications.
3. Enhanced Education and Training: Minnesota has invested in providing education and training to healthcare providers on topics such as pain management, addiction, and alternative treatments for chronic pain. This helps ensure that providers are equipped to address the opioid crisis effectively.
4. Naloxone Access: Minnesota has expanded access to naloxone, a life-saving medication that can reverse opioid overdoses. This is crucial in preventing opioid-related fatalities and providing immediate assistance in emergency situations.
5. Treatment and Recovery Programs: The state has also focused on expanding access to treatment and recovery programs for individuals struggling with opioid use disorder. This includes medication-assisted treatment, counseling services, and support groups.
By implementing these measures, Minnesota aims to reduce opioid misuse, prevent overdoses, and support individuals in their journey towards recovery.
14. Are there any restrictions on prescribing opioids to pregnant women in Minnesota?
In Minnesota, there are specific restrictions and guidelines regarding the prescription of opioids to pregnant women due to the potential risks and implications for both the mother and the fetus. Health care providers are advised to exercise caution when prescribing opioids to pregnant women and consider alternative pain management strategies whenever possible. Some of the key restrictions and considerations in Minnesota include:
1. Education and Informed Consent: Health care providers are required to educate pregnant patients about the risks associated with opioid use during pregnancy and obtain informed consent before initiating opioid therapy.
2. Monitoring and Evaluation: Pregnant women prescribed opioids should be closely monitored throughout the course of treatment to assess the effectiveness of the medication and watch for any potential adverse effects.
3. Neonatal Abstinence Syndrome (NAS): Opioid use during pregnancy can lead to the development of NAS in newborns, which can result in withdrawal symptoms after birth. Health care providers need to be aware of this risk and take appropriate steps to manage NAS if it occurs.
4. Prescription Drug Monitoring Program (PDMP): Health care providers are encouraged to utilize the state’s PDMP to monitor opioid prescriptions for pregnant patients and prevent misuse or abuse.
5. Collaboration with Maternal-Fetal Medicine Specialists: In certain cases, it may be advisable for health care providers to collaborate with maternal-fetal medicine specialists to ensure the safe and appropriate management of pain in pregnant women.
Overall, healthcare providers in Minnesota must be mindful of the unique considerations and potential risks associated with prescribing opioids to pregnant women and take necessary precautions to protect the health and well-being of both the mother and the developing fetus.
15. How are healthcare providers in Minnesota held accountable for opioid prescribing practices?
Healthcare providers in Minnesota are held accountable for their opioid prescribing practices through a variety of regulatory mechanisms and initiatives aimed at combatting opioid misuse and abuse. Here are some ways in which they are held accountable:
1. Prescription Monitoring Program (PMP): Minnesota operates a PMP which requires healthcare providers to review a patient’s prescription history before prescribing opioids. This helps identify potential cases of overprescribing or diversion.
2. Continuing Education Requirements: Healthcare providers in Minnesota are required to complete continuing education on safe opioid prescribing practices, pain management, and addiction awareness to ensure they are up-to-date on best practices and guidelines.
3. Professional Guidelines: Organizations such as the Minnesota Medical Association and the Minnesota Board of Medical Practice have established guidelines and protocols for safe opioid prescribing practices that healthcare providers are expected to follow.
4. Regulatory Oversight: The Minnesota Board of Medical Practice monitors healthcare providers’ prescribing practices and has the authority to investigate complaints and take disciplinary action if necessary.
5. Collaboration with Law Enforcement: Healthcare providers may also be held accountable through collaboration with law enforcement agencies in cases of opioid diversion or illegal prescribing practices.
Overall, healthcare providers in Minnesota are subject to a range of accountability measures designed to promote safe and responsible opioid prescribing practices and prevent misuse and abuse within the state.
16. Does Minnesota have a prescription drug monitoring program for opioids?
Yes, Minnesota does have a prescription drug monitoring program (PDMP) for opioids. The program, known as the Minnesota Prescription Monitoring Program (PMP), was established to help combat prescription drug abuse and diversion. Healthcare providers in Minnesota are required to review a patient’s prescription history in the PMP before prescribing opioids or other controlled substances to ensure safe and appropriate use. The PMP allows healthcare providers and pharmacists to track a patient’s controlled substance prescriptions and identify potential red flags, such as doctor shopping or excessive opioid prescriptions. By utilizing the PMP, healthcare providers can make more informed decisions when prescribing opioids, ultimately helping to prevent misuse and abuse.
17. What resources are available in Minnesota for individuals struggling with opioid addiction?
In Minnesota, there are numerous resources available to support individuals struggling with opioid addiction. These resources include:
1. Treatment Centers: Minnesota has various treatment centers and facilities that offer programs for individuals battling opioid addiction. These centers provide medical detoxification, counseling, therapy, and support services to help individuals overcome their addiction.
2. Support Groups: There are several support groups in Minnesota specifically tailored for individuals struggling with opioid addiction. These groups, such as Narcotics Anonymous (NA) and SMART Recovery, offer a community of peers who understand the challenges of addiction and provide encouragement and guidance.
3. Hotlines and Helplines: Various hotlines and helplines operate in Minnesota to provide immediate assistance and support to individuals in crisis. These resources offer confidential support, information, and referrals to treatment programs and services.
4. State and Local Government Programs: Minnesota state and local governments offer programs and initiatives to address opioid addiction, including prevention, treatment, and recovery support services. These programs aim to reduce the impact of opioids on communities and individuals.
5. Healthcare Providers: Medical professionals, including doctors, therapists, and counselors, play a crucial role in supporting individuals struggling with opioid addiction. They can provide treatment, medication-assisted therapy, and ongoing care to help individuals recover from addiction.
Overall, the resources available in Minnesota for individuals struggling with opioid addiction are diverse and comprehensive, providing different avenues for support and recovery. It is essential for individuals battling addiction to reach out and utilize these resources to overcome their struggles and lead healthier, substance-free lives.
18. What measures has Minnesota implemented to reduce opioid overdose deaths?
Minnesota has implemented several measures to reduce opioid overdose deaths, including:
1. Prescription Monitoring Program (PMP): Minnesota has a robust PMP that tracks controlled substance prescriptions, allowing healthcare providers to identify and prevent potential misuse or diversion of opioids.
2. Opioid prescribing guidelines: The state has developed and promoted guidelines for healthcare providers on safe and appropriate opioid prescribing practices to reduce the risk of addiction and overdose.
3. Naloxone access: Minnesota has expanded access to naloxone, an opioid overdose reversal medication, by allowing pharmacists to dispense it without a prescription and ensuring that first responders are equipped with naloxone.
4. Drug take-back programs: The state has implemented programs for the safe disposal of unused or expired prescription medications, including opioids, to prevent their misuse and diversion.
5. Opioid education and awareness campaigns: Minnesota has conducted public education campaigns to raise awareness about the risks of opioid misuse, addiction, and overdose, as well as to provide resources for those struggling with opioid use disorder.
Overall, these measures aim to address the opioid epidemic in Minnesota by promoting responsible opioid prescribing, increasing access to overdose reversal medications, and educating the public about the dangers of opioids.
19. Are there any limitations on prescribing opioids for chronic pain in Minnesota?
Yes, there are limitations on prescribing opioids for chronic pain in Minnesota. Some of the key regulations and guidelines include:
1. The Minnesota Prescription Monitoring Program (PMP): Healthcare providers are required to check the PMP database before prescribing opioids to monitor a patient’s prescription history and identify potential signs of misuse or abuse.
2. Opioid Prescribing Limits: There are specific limits on the quantity and duration of opioid prescriptions for acute and chronic pain, with restrictions on refills and dosage strengths.
3. Continuing Education Requirements: Healthcare providers in Minnesota are mandated to complete continuing education on safe opioid prescribing practices to enhance their knowledge and skills in pain management.
4. Patient Evaluation and Monitoring: Healthcare providers are expected to conduct thorough patient evaluations, implement treatment agreements, and regularly monitor patients receiving chronic opioid therapy to mitigate risks of misuse and overdose.
5. Non-Opioid Treatment Options: Healthcare providers are encouraged to explore and consider non-opioid treatment alternatives for managing chronic pain, such as physical therapy, acupuncture, cognitive-behavioral therapy, and non-opioid medications.
These limitations and regulations aim to promote safe and responsible opioid prescribing practices, reduce the risk of opioid misuse and addiction, and improve patient outcomes in the management of chronic pain in Minnesota.
20. How does Minnesota regulate the disposal of unused opioids?
In Minnesota, the regulations for the disposal of unused opioids are outlined in the Minnesota Statutes Section 151.37. The state has implemented several measures to ensure the safe and proper disposal of these medications:
1. Authorized collectors: Minnesota allows for the establishment of authorized collectors, such as pharmacies, hospitals, and law enforcement agencies, where individuals can safely drop off their unused opioids for disposal.
2. Mail-back programs: The state also permits mail-back programs that allow individuals to mail their unused opioids to authorized facilities for proper disposal.
3. Guidelines for disposal: Minnesota provides guidelines on how to dispose of opioids at home, such as mixing the medications with an undesirable substance like coffee grounds or cat litter before throwing them in the trash.
4. Education and awareness: The state emphasizes the importance of educating the public about the risks of keeping unused opioids at home and encourages proper disposal to prevent misuse and diversion.
By implementing these regulations and measures, Minnesota aims to reduce the availability of unused opioids in households, minimize the risk of accidental exposure, and combat the opioid crisis in the state.
Spanish 
English